Tibor Schuster
Capecitabine plus paclitaxel versus epirubicin plus paclitaxel as first-line treatment for metastatic breast cancer: efficacy and safety results of a randomized, phase III trial by the AGO Breast Cancer Study Group
Lück H, Schuster T, Wollschläger K, Untch M, Thomssen C, Eidtmann H, Stickeler E, Richter B, Hubalek M, Jackisch C, Stähler A, Beckmann M, Heilmann V, Huober J, Schrader I, Loibl S, du Bois A, von Minckwitz G. Capecitabine plus paclitaxel versus epirubicin plus paclitaxel as first-line treatment for metastatic breast cancer: efficacy and safety results of a randomized, phase III trial by the AGO Breast Cancer Study Group. Breast Cancer Res Treat 2013; 139:779-87.
Jun 15, 2013Capecitabine plus paclitaxel versus epirubicin plus paclitaxel as first-line treatment for metastatic breast cancer: efficacy and safety results of a randomized, phase III trial by the AGO Breast Cancer Study Group
Jun 15, 2013Breast Cancer Res Treat 2013; 139:779-87
Lück Hans-Joachim, Schuster Tibor, Wollschläger Kerstin, Untch Michael, Thomssen Christoph, Eidtmann Holger, Stickeler Elmar, Richter Barbara, Hubalek Michael, Jackisch Christian, Stähler Ann, Beckmann Matthias, Heilmann Volker, Huober Jens, Schrader Iris, Loibl Sibylle, du Bois Andreas, von Minckwitz Gunter
Imaging proliferation to monitor early response of lymphoma to cytotoxic treatment
Graf N, Dechow T, Schwaiger M, Peschel C, zum Büschenfelde C, Senekowitsch-Schmidtke R, Wester H, Schuster T, Fend F, den Hollander J, Herrmann K, Buck A. Imaging proliferation to monitor early response of lymphoma to cytotoxic treatment. Mol Imaging Biol 2008; 10:349-55.
Aug 14, 2008Imaging proliferation to monitor early response of lymphoma to cytotoxic treatment
Aug 14, 2008Mol Imaging Biol 2008; 10:349-55
Graf Nicolas, Dechow Tobias, Schwaiger Markus, Peschel Christian, zum Büschenfelde Christian Meyer, Senekowitsch-Schmidtke Reingard, Wester Hans-Jürgen, Schuster Tibor, Fend Falko, den Hollander Jürgen, Herrmann Ken, Buck Andreas K